Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-06840003

🥰Excellent
Catalog No. T4307Cas No. 198474-05-4
Alias PF 06840003, EOS200271

PF-06840003 (EOS200271) is a specific and orally active IDO-1 inhibitor.

PF-06840003

PF-06840003

🥰Excellent
Purity: 99.89%
Catalog No. T4307Alias PF 06840003, EOS200271Cas No. 198474-05-4
PF-06840003 (EOS200271) is a specific and orally active IDO-1 inhibitor.
Pack SizePriceAvailabilityQuantity
2 mg$38In Stock
5 mg$61In Stock
10 mg$85In Stock
25 mg$133In Stock
50 mg$182In Stock
100 mg$288In Stock
1 mL x 10 mM (in DMSO)$108In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "PF-06840003"

Select Batch
Purity:99.89%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PF-06840003 (EOS200271) is a specific and orally active IDO-1 inhibitor.
Targets&IC50
IDO1 (mouse):1.5 μM, IDO1 (human):0.41 μM, dIDO1:0.59 μM
In vitro
The s of PF-06840003 has inhibitory for hIDO-1 (IC50: 0.41 μM), mouse IDO-1 (IC50: 1.5 μM) and dog IDO-1 (IC50: 0.59 μM), respectively. It has very weak inhibitory against hTDO-2 (IC50: 140 μM). In cellular assays, PF-06840003 shows activity both in the LPS/INFγ-stimulated THP1 cells (IC50: 1.7 μM) and in the HeLa assay (IC50: 1.8 μM). PF-06840003 is a very weak inhibitory against CYPs (IC50>100 μM) except 2C19 (IC50: 78 μM).
In vivo
In mice, PF-06840003 reduces intratumoral kynurenine levels (>80%). In multiple preClinicalal syngeneic models in mice, It inhibits tumor growth by combinated with immune checkpoint inhibitors. PF-0684003 has favorable predicted human pharmacokinetic properties, including a predicted t1/2 of 16-19 hours.
AliasPF 06840003, EOS200271
Chemical Properties
Molecular Weight232.21
FormulaC12H9FN2O2
Cas No.198474-05-4
SmilesFc1ccc2[nH]cc(C3CC(=O)NC3=O)c2c1
Relative Density.1.464 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 60 mg/mL (258.39 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.3064 mL21.5322 mL43.0645 mL215.3223 mL
5 mM0.8613 mL4.3064 mL8.6129 mL43.0645 mL
10 mM0.4306 mL2.1532 mL4.3064 mL21.5322 mL
20 mM0.2153 mL1.0766 mL2.1532 mL10.7661 mL
50 mM0.0861 mL0.4306 mL0.8613 mL4.3064 mL
100 mM0.0431 mL0.2153 mL0.4306 mL2.1532 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-06840003 | purchase PF-06840003 | PF-06840003 cost | order PF-06840003 | PF-06840003 chemical structure | PF-06840003 in vivo | PF-06840003 in vitro | PF-06840003 formula | PF-06840003 molecular weight